OUR VISION IS TO REDUCE ILLNESS AND DEATH ASSOCIATED WITH FUNGAL DISEASES WORLDWIDE.

Introduction

Fungal Infections are neglected diseases worldwide. Globally, over 300 million people of all ages suffer from a serious fungal infection every year. Of these over 1.35 million people are estimated to die. In comparison deaths from malaria and tuberculosis are 1.2 and 1.4 million respectively. Most serious fungal infections are ‘hidden’ because of other health problems such as, AIDS, cancer, transplantation, or immunosuppression. How do you feed your children when your blindness stops you from working? Tens of thousands lose their eyesight every year from fungal keratitis. It is rarely diagnosed and treated. Serious fungal infections require specialized testing.
Our country representatives have presented burden of fungal disease in their country at the ICAAC conference in Washington DC, the most recent of several efforts to estimate burdens. The world's estimated burdens we described in a recent plenary lecture at Montreal by GAFFI's President (View). Antifungal drug availability (generics) is also a major limitation to improved outcome, linked here on the GAFFI website. Antifungal drug prices and availability across the world varies a great deal by country –  view.
Working with The Wellcome Trust through Aberdeen.

“GAFFI's direct network now extends to more than 50 countries in all continents. GAFFI has made important progress in its diagnostic assessment and development programs, in health professional education with its partner LIFE-worldwide and in estimating both country and global burdens of fungal diseases.”